by Kelsey Olson | Apr 28, 2023 | Events, Featured, Great Plains QIN, Health Equity, Patient Safety, Quality Care Coalition
Join North Dakota State University Department of Public Health and Dr. Nizar Wehbi, North Dakota State Health Officer, as we hear from regional experts as they discuss their experience in the field and the role public health influences the lives in North Dakota both...
by Kelsey Olson | Apr 28, 2023 | Featured, Great Plains QIN, Nursing Home Quality, Patient Safety, Public Observances, Quality Care Coalition
It is National Nurses Month. The first week is all about self-care. Nursing is a rewarding and challenging profession so it’s critical you have access to authentic support systems and tools. Prioritize your self-care by engaging in healthy activities that target both...
by Kelsey Olson | Apr 28, 2023 | Cardiac Care, Chronic Disease Self-Management, Featured, Great Plains QIN, Home Health, Hospitals, Nursing Home Quality, Patient Safety, Public Observances, Quality Care Coalition
May is National Stroke Awareness Month, a time when healthcare professionals and public health advocates aim to raise awareness about the warning signs and risk factors of stroke. Stroke is the fifth leading cause of death in the United States, and it can cause...
by Keri McDermott | Apr 25, 2023 | Featured, Great Plains QIN, Health Equity, Quality Care Coalition
The Great Plains QIN team is excited to announce our new series, Continuing the Conversation, a webinar series focused on the interdependent components to achieving health equity. Register Today. Great Plains QIN hosted an information-packed session in April –...
by Kelsey Olson | Apr 24, 2023 | Antibiotic Stewardship, Behavioral Health Outcomes, Chronic Disease Self-Management, Featured, Great Plains QIN, Medication Safety, Nursing Home Quality, Opioids, Patient Safety, Quality Care Coalition
The FDA has made several updates to its opioid prescribing information, including new warnings about the possibility for increased pain, which can lead to dangerous adverse reactions, such as respiratory depression. Visit the FDA site for updates on prescribing...
by Kelsey Olson | Apr 24, 2023 | Behavioral Health Outcomes, Featured, Great Plains QIN, Health Equity, Home Health, Patient Safety, Quality Care Coalition
Rural suicide is a critical issue that needs urgent attention as it has become a growing concern in recent years. Suicide rates in rural areas are often higher than in urban areas. Factors, such as limited access to mental health services, social isolation and lack of...
by Kelsey Olson | Apr 24, 2023 | Antibiotic Stewardship, Care Coordination, Chronic Disease Self-Management, Featured, Great Plains QIN, Health Equity, Hospitals, Immunizations, Medication Safety, Nursing Home Quality, Patient Safety, Quality Care Coalition
The Friday Focus 4 Health May Series begins on May 5, 2023 Up Your Protection From Infections | 12:15 – 12:45 pm CT Our Friday Focus 4 Health Series is intended to jump start or augment your current quality improvement efforts. Participants will connect across the...
by Kelsey Olson | Apr 24, 2023 | Care Coordination, Featured, Great Plains QIN, Home Health, Opioids, Patient Safety, Quality Care Coalition
The U.S. Food and Drug Administration (FDA) has announced new requirements for manufacturers of opioid analgesics (painkillers) dispensed in outpatient settings. The FDA is now requiring these manufacturers to provide prepaid mail-back envelopes as an additional...
by Keri McDermott | Apr 18, 2023 | Chronic Disease Self-Management, Diabetes Care, Featured, Great Plains QIN, Health Equity, Patient Safety, Quality Care Coalition, Quality of Care Transitions
We are reaching out in partnership and to support the Helpline Center in South Dakota. The Helpline Center is providing services in your community via 211. It is a free, 3-digit number people can call 24/7 for any kind of non-profit, social service, government and...
by Keri McDermott | Apr 17, 2023 | Featured, Great Plains QIN, Medication Safety, Opioids, Patient Safety, Quality Care Coalition
Xylazine’s growing role in overdose deaths nationwide prompts Administration to make this designation for the first time in U.S. history. Access the White House Brief Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), has...
